Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Cyclically Adjusted Revenue per Share: ﷼0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:2070 Saudi Pharmaceutical Industries & Medical Appliances Corp SAU:2070
68 GF Score
Price ﷼30.96
GF Value ﷼31.32
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted Revenue per Share?

Saudi Pharmaceutical Industries & Medical Appliances SAU:2070 +0.52% 68 Cyclically Adjusted Revenue per Share is ﷼0.00 as of Jun. 2026. GuruFocus rates SAU:2070 with a GF Score™ of 68/100 and a GF Value™ of ﷼31.32 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Saudi Pharmaceutical Industries & Medical Appliances's adjusted revenue per share for the three months ended in Jun. 2026 was ﷼4.107. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ﷼0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Saudi Pharmaceutical Industries & Medical Appliances's average Cyclically Adjusted Revenue Growth Rate was 0.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Saudi Pharmaceutical Industries & Medical Appliances was 4.10% per year. The lowest was 0.60% per year. And the median was 2.60% per year.

As of today (2026-08-14), Saudi Pharmaceutical Industries & Medical Appliances's current stock price is ﷼30.96. Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ﷼0.00. Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Saudi Pharmaceutical Industries & Medical Appliances was 4.45. The lowest was 1.48. And the median was 2.12.


Saudi Pharmaceutical Industries & Medical Appliances  (SAU:2070) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Saudi Pharmaceutical Industries & Medical Appliances was 4.45. The lowest was 1.48. And the median was 2.12.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted Revenue per Share Related Terms


Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted Revenue per Share Chart

Saudi Pharmaceutical Industries & Medical Appliances Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.79 14.50 14.73 14.90 14.77

Saudi Pharmaceutical Industries & Medical Appliances Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.99 15.08 14.77 15.03 0.00

SAU:2070 vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted PS Ratio falls into.


SAU:2070
68GF Score
Saudi Pharmaceutical Industries & Medical Appliances Corp SAU:2070
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Saudi Pharmaceutical Industries & Medical Appliances's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.107/333.9520*333.9520
=4.107

Current CPI (Jun. 2026) = 333.9520.

Saudi Pharmaceutical Industries & Medical Appliances Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.143 241.428 2.964
201612 2.831 241.432 3.916
201703 3.276 243.801 4.487
201706 2.551 244.955 3.478
201709 2.313 246.819 3.130
201712 3.422 246.524 4.636
201803 3.257 249.554 4.359
201806 2.478 251.989 3.284
201809 1.857 252.439 2.457
201812 5.007 251.233 6.656
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 2.856 256.759 3.715
201912 2.869 256.974 3.728
202003 3.964 258.115 5.129
202006 2.734 257.797 3.542
202009 3.108 260.280 3.988
202012 3.154 260.474 4.044
202103 3.790 264.877 4.778
202106 2.716 271.696 3.338
202109 2.595 274.310 3.159
202112 3.064 278.802 3.670
202203 3.244 287.504 3.768
202206 2.589 296.311 2.918
202209 2.975 296.808 3.347
202212 3.040 296.797 3.421
202303 4.431 301.836 4.902
202306 3.400 305.109 3.721
202309 3.176 307.789 3.446
202312 2.822 306.746 3.072
202403 3.974 312.332 4.249
202406 3.277 314.175 3.483
202409 3.644 315.301 3.860
202412 3.241 315.605 3.429
202503 4.060 319.799 4.240
202506 3.439 322.561 3.560
202509 3.450 324.800 3.547
202512 3.400 324.054 3.504
202603 3.551 330.213 3.591
202606 4.107 333.952 4.107

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ﷼0.00 mean?
Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) has a Cyclically Adjusted Revenue per Share of ﷼0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors.
Is Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted Revenue per Share too high?
Saudi Pharmaceutical Industries & Medical Appliances' current Cyclically Adjusted Revenue per Share is ﷼0.00. Overall, Saudi Pharmaceutical Industries & Medical Appliances has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted Revenue per Share of ﷼0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors. Saudi Pharmaceutical Industries & Medical Appliances's current Cyclically Adjusted Revenue per Share is ﷼0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Pharmaceutical Industries & Medical Appliances stock overvalued right now?
Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) is currently considered Fairly Valued. The stock's GF Value™ is ﷼31.32, compared to a current price of ﷼30.96 — trading 1.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ﷼0.00. Saudi Pharmaceutical Industries & Medical Appliances' overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070), the current Cyclically Adjusted Revenue per Share is ﷼0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Overvalued in 2026?

Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances stock appears to be undervalued. The current stock price of ﷼30.96 is trading 1.1% below its estimated GF Value™ of ﷼31.32. GuruFocus considers Saudi Pharmaceutical Industries & Medical Appliances to be Fairly Valued.

Key valuation signals for SAU:2070:

  • Cyclically Adjusted Revenue per Share: ﷼0.00
  • GF Value™: ﷼31.32 vs. price of ﷼30.96 (1.1% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the SAU:2070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Saudi Pharmaceutical Industries & Medical Appliances Business Description

Address King Abdul Aziz Road, Industrial City of Al-Qassim, Buraidah, SAU
Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. The segments of the company are Pharmaceutical Manufacturing, Trading and Distribution services, and Healthcare Services, out of which the company derives maximum revenue from the Pharmaceutical Manufacturing segment. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria.
68GF Score

Get the complete analysis for SAU:2070

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼30.96
Price
﷼31.32
GF Value